Principles of transparency and best practice in scholarly publishing
The Principles of Transparency and Best Practice in Scholarly Publishing (joint statement by Committee on Publication Ethics, Directory of Open Access Journals, World Association of Medical Editors, and Open Access Scholarly Publishers Association) 1) is the most popular international standard of publication ethics and will be employed in this editorial. The principles consist of 16 items, each of which will be reviewed for journal compliance.
Elsevier also announced the "publication ethics and malpractice statement requirements" in June 2015, 2) which includes 10 items: (1) editorial board, (2) authors and authors responsibilities, (3) peer-review process, (4) publication ethics including guidelines for retracting or correcting articles and publication of corrections, clarifications, retractions and apologies, (5) copyright and access, (6) archiving, (7) ownership and management, (8) web site, (9) publishing schedule, and (10) name of journal. Those 10 items are already included in the Principles of Transparency and Best Practice in Scholarly Publishing.
1)
The results are summarized in 
Institutional review board and informed consent
Aside from the above Principles of Transparency and Best Practice in Scholarly Publishing, informed consent and institutional review board (IRB) approval for human subjects or human-originating materials research is well described at the journal homepage and in the print version. These 2 components are mandatory for medical journals according to Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals.
3) The compliance of the journal was screened for issues published in 2017 (volume 22).
The number of original articles published in 2017 was 18. The results regarding IRB approval and receipt of informed consent are presented in Table 2 . All subjects of original articles were human. Out of 18 articles, there were 15 chart reviews, 3 cross-sectional observational studies, 1 cohort study, and 1 online survey. Although informed consent was not described in IRBapproved studies, it was presumed to have been obtained because the need for informed consent is addressed prior to IRB approval. Usually, the need for informed consent was www.e-apem.org waived in retrospective chart review studies. If a study is not a clinical interventional study or does not include an identifiable photo of the subject, informed consent can be waived by the IRB. It would be better to confirm IRB approval and waiver of informed consent in all human subject chart review studies.
There is an article in the Annals of Pediatric Endocrinology & Metabolism that analyzed data from the 10th Korea Youth Risk Behavior web-based survey conducted in 2014 by the Ministry of Education, the Ministry of Health and Welfare and the Korea Centers for Disease Control and Prevention, Korean Government. 4) IRB approval was waived for this survey according to the "enforcement rule of bioethics and safety act" available from: http://www.law.go.kr/LSW/lsInfoP. 
